Mission Live Forever: Crypto Billionaire, Bioengineer incubate projects for anti-aging

New Delhi, Jan 2: Man will not grow old. His lifespan will increase for centuries together. His health-span will fight anti-ageing, hope a Crypto Billionaire and a Bio-Engineer. The two techies are working out with an innovative project to see humans live forever. They have rolled out a human life-based start-up under the aegis of ‘NewLimit’. The enthusiasts are Crypto Billionaire, Brian Armstrong and Bioengineer & Tech investor tycoon Blake Byers, who are the Co-founders of the ‘NewLimit”.  Both the ambitious researchers are now in search of rejuvenating the younger body with the weaker physique and diminishing mind of an old man. According to Armstrong, CEO of Coinbase, and Byers, who has a PhD in Bioengineering from Stanford University, the goal focuses on and prioritises the extension of the health-span of human life as opposed to just lifespan. It aims to improve the quality of life in age-related health issues. “Imagine if you could live the same number of years, but be free from pain, and have the same mobility and cognition as someone in their thirties. If we could maintain this state, how many of us would still want to have our lifespan end at the ‘normal’ time” the founders stated in a press release last week. “Ageing is one of the largest sources of pain and suffering hiding in plain sight all around us, and we believe there is a moral imperative to try and end this suffering that affects every one of us,” they continued. “NewLimit plans to initially focus on this mechanism, especially, epigenetic reprogramming. Put simply, we want to figure out a way to restore the regenerative potential we all had when we were younger but somehow lost. The last year has emphasised this point on a global scale. We still do not know why the elderly have a weaker immune system and are more susceptible to infection and receive less protection from vaccines,” the founders claimed. The company’s first step to such programming is to develop the necessary “machine learning models” to understand what changes occur in our bodies with age and how they can be stopped or even reversed. The entrepreneurs claimed that, like most state-of-the-art breakthrough advancements which often first come with a hefty price tag, the same will occur with NewLimit. However, over time the cost of anything new drives down and becomes increasingly accessible to everyone. “Some of these products take decades to get to lower costs, but we hope to move much faster than that,” they stated. The company is still in its infant stages, with its founding team yet to be completely formed. NewLimit is currently on the lookout for like-minded individuals interested in the pursuit and progression of biotech. Input noted how the founders reference these claims from Nobel Prize-winning research, first published in 2006, that describes these four proteins as “Yamanaka factors” and uses them “to reprogram aged cells into immature cells—creating stem cells, the undifferentiated cells common in embryos, from the plain old issue in your body right now.” This is what NewLimit hopes to utilise in its aim to aid age-related health concerns and bring back the regenerative qualities of our bodies in youth. However, the techies acknowledged, the pursuit to ‘cure’ ageing is “ambitious” and will likely take many, many decades to come to successful fruition (if possible), they’ve also added that it is imperative for them to start as soon as possible. NewLimit hopes to do this through epigenetics which is a phenomenon that began 15 years ago—a discovery that showed that “your cells are far more plastic than the previously assumed.” With as little as four proteins, cells can be completely changed. The idea of the historic human desire, to ‘cure’ ageing has been a prevalent, unwavering topic in our scientific discussions. If the venture of the NewLimit pluck fruits, man will lead a joyous life even in his old age as he was in his earlier adolescence, said Armstrong and Byers.